sarepta therapeutics ceo on soaring stock and drug development
Published 6 years ago • 2.4K plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
3:51
td cowen's ritu bara talks sarepta stock skyrocketing on fda gene therapy approval
-
5:43
sarepta ceo on what's next after expanded muscular dystrophy drug approval
-
4:09
watch cnbc's full interview with sarepta ceo doug ingram
-
3:31
sarepta ceo doug ingram: we should be profitable by the end of next year if we achieve our goals
-
6:24
ptc therapeutics cfo: rare potential | mad money | cnbc
-
33:59
chart this: newer dow theory flashes confirmed bull signal (11/25/24)
-
10:54
hemogenyx pharmaceuticals explains share consolidation, greenlight for clinical trial
-
41:47
what if this is the minsky moment right now?
-
2:47
sarepta shares tumble as concerns mount over fda approval on gene therapy
-
5:00
biotech analyst discusses her top stock picks: biogen & sarepta therapeutics
-
6:41
former fda commissioner dr. scott gottlieb on the future of gene therapy
-
8:42
astrazeneca ceo pascal soriot goes one-on-one with jim cramer
-
7:45
sarepta therapeutics (srpt) massive selloff | heres what to do
-
4:12
'fast money' traders talk the upcoming slate of retail earnings
-
3:30
caspin resources makes mineralisation breakthrough at serradella
-
0:26
thestreet's jim cramer says the easy money has been made in sarepta
-
9:00
sarepta stock analysis - massive growth potential
-
1:00
opening bell, september 7, 2018
-
6:43
ark invests in sarepta therapeutics! srpt falls 50%! muscle drug fails?